← 產業報告目錄
Whole Exome Sequencing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables, Services), By Technology (synthesis, ion semiconductor sequencing), By Workflow (pre-sequencing, sequencing and data analysis), By Application (clinical diagnostics, drug discovery & development, personalized medicine), By End-use, By Region, And Segment Forecasts, 2023-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-05頁數 180報告編號 INSIGHTACE-dd553c70af
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The global Whole Exome Sequencing Market is forecasted to expand at a compound annual growth rate of 20.7% throughout the 2023–2031 forecast period.
At its core, Whole Exome Sequencing pertains to The entire exome sequencing has a wide range of clinical applications since it can distinguish between disease-causing mutations or disease variants while identifying exon regions' alterations. Stakeholders across the healthcare landscape are surgingly turning to these solutions to meet contemporary demands.
Market momentum is supported by surging need advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region forecasted to deliver the strongest growth trajectory through the forecast period, supported by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Whole Exome Sequencing Market Snapshot
Chapter 4. Global Whole Exome Sequencing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:
5.2.1. Instruments
5.2.2. Consumables
5.2.3. Services
Chapter 6. Market Segmentation 2: by Technology Estimates & Trend Analysis
6.1. by Technology & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Technology:
6.2.1. Sequencing by Synthesis
6.2.2. ION Semiconductor Sequencing
6.2.3. Others
Chapter 7. Market Segmentation 3: by Workflow Estimates & Trend Analysis
7.1. by Workflow & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Workflow:
7.2.1. Pre-sequencing
7.2.2. Sequencing
7.2.3. Data Analysis
Chapter 8. Market Segmentation 4: by Application Estimates & Trend Analysis
8.1. by Application & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
8.2.1. Clinical Diagnostics
8.2.2. Drug Discovery & Development
8.2.3. Personalized Medicine
8.2.4. Others
Chapter 9. Market Segmentation 5: by End-use Estimates & Trend Analysis
9.1. by End-use & Market Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-use:
9.2.1. Academic & Research Institutes
9.2.2. Hospitals & Clinics
9.2.3. Pharmaceutical & Biotechnology Companies
9.2.4. Others
Chapter 10. Whole Exome Sequencing Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Whole Exome Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
10.1.2. North America Whole Exome Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2023-2031
10.1.3. North America Whole Exome Sequencing Market revenue (US$ Million) by Workflow, 2023-2031
10.1.4. North America Whole Exome Sequencing Market revenue (US$ Million) by Application, 2023-2031
10.1.5. North America Whole Exome Sequencing Market revenue (US$ Million) by End-use, 2023-2031
10.1.6. North America Whole Exome Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
10.2. Europe
10.2.1. Europe Whole Exome Sequencing Market revenue (US$ Million) by Product Type, 2023-2031
10.2.2. Europe Whole Exome Sequencing Market revenue (US$ Million) by Technology, 2023-2031
10.2.3. Europe Whole Exome Sequencing Market revenue (US$ Million) by Workflow, 2023-2031
10.2.4. Europe Whole Exome Sequencing Market revenue (US$ Million) by Application, 2023-2031
10.2.5. Europe Whole Exome Sequencing Market revenue (US$ Million) by End-use, 2023-2031
10.2.6. Europe Whole Exome Sequencing Market revenue (US$ Million) by country, 2023-2031
10.3. Asia Pacific
10.3.1. Asia Pacific Whole Exome Sequencing Market revenue (US$ Million) by Product Type, 2023-2031
10.3.2. Asia Pacific Whole Exome Sequencing Market revenue (US$ Million) by Technology, 2023-2031
10.3.3. Asia-Pacific Whole Exome Sequencing Market revenue (US$ Million) by Workflow, 2023-2031
10.3.4. Asia Pacific Whole Exome Sequencing Market revenue (US$ Million) by Application, 2023-2031
10.3.5. Asia Pacific Whole Exome Sequencing Market revenue (US$ Million) by End-use, 2023-2031
10.3.6. Asia Pacific Whole Exome Sequencing Market revenue (US$ Million) by country, 2023-2031
10.4. Latin America
10.4.1. Latin America Whole Exome Sequencing Market revenue (US$ Million) by Product Type, 2023-2031
10.4.2. Latin America Whole Exome Sequencing Market revenue (US$ Million) by Technology, 2023-2031
10.4.3. Latin America Whole Exome Sequencing Market revenue (US$ Million) by Workflow, 2023-2031
10.4.4. Latin America Whole Exome Sequencing Market revenue (US$ Million) by Application, 2023-2031
10.4.5. Latin America Whole Exome Sequencing Market revenue (US$ Million) by End-use, 2023-2031
10.4.6. Latin America Whole Exome Sequencing Market revenue (US$ Million) by country, 2023-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Whole Exome Sequencing Market revenue (US$ Million) by Product Type, 2023-2031
10.5.2. Middle East & Africa Whole Exome Sequencing Market revenue (US$ Million) by Technology, 2023-2031
10.5.3. Middle East & Africa Whole Exome Sequencing Market revenue (US$ Million) by Workflow, 2023-2031
10.5.4. Middle East & Africa Whole Exome Sequencing Market revenue (US$ Million) by Application, 2023-2031
10.5.5. Middle East & Africa Whole Exome Sequencing Market revenue (US$ Million) by End-use, 2023-2031
10.5.6. Middle East & Africa Whole Exome Sequencing Market revenue (US$ Million) by country, 2023-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Thermo Fisher Scientific, Inc
11.2.2. Illumina, Inc.
11.2.3. Agilent Technologies, Inc
11.2.4. BGI
11.2.5. Psomagen
11.2.6. Hoffmann-La Roche Ltd
11.2.7. Azenta US Inc. (GENEWIZ)
11.2.8. CD Genomics
11.2.9. Novogene Co, Ltd
11.2.10. Eurofins Genomics
11.2.11. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們